Your "facts" sound like KV Pharmaceutical propaganda to me.
KV Pharmaceutical did not CREATE 17P, nor did they spend a "ton" of money to get it approved by the FDA. (They are dangerously close to bankruptcy http://www.bizjournals.com/stlouis/stories/2009/07/20/daily80.html, but I'm sure they have our babies' best interest at heart.) The medicine has been around since the 1950s and has previously cost $200 per pregnancy. So, they'll be making a $29,800 profit on every woman that requires the injections.
Aetna is ONE insurance company of several, but sure, I'll go with your math. If 1,000 Aetna customers require 17P in one year, KV Pharmaceutical just made $29,800,000. Add in Blue Cross/Blue Shield, United Healthcare, Humana and others, that's over $100 million in ONE year. And of course, don't forget all the uninsured women who will need the shots, so that's several million dollars more that Medicaid will be spending...and we all know that the government is just rolling around in extra money right now.
So let's review: KV Pharmaceutical did not develop the drug (they merely pushed the paperwork on a drug that already existed and had been researched by the National Institute of Health-funded by TAX dollars), nor does the drug help less than 200,000 people a year. Therefore, it does not qualify for "orphan drug" status.
The "orphan drug" status is meant to help people with RARE disorders, not prey on women and babies for a obscene profit.
If those aren't enough facts for you, hear what Dr. Dombrowski has to say: http://www.youtube.com/watch?v=55J4VFnuhGU
Comment Reply
Your "facts" sound like KV Pharmaceutical propaganda to me.
KV Pharmaceutical did not CREATE 17P, nor did they spend a "ton" of money to get it approved by the FDA. (They are dangerously close to bankruptcy http://www.bizjournals.com/stlouis/stories/2009/07/20/daily80.html, but I'm sure they have our babies' best interest at heart.) The medicine has been around since the 1950s and has previously cost $200 per pregnancy. So, they'll be making a $29,800 profit on every woman that requires the injections.
Aetna is ONE insurance company of several, but sure, I'll go with your math. If 1,000 Aetna customers require 17P in one year, KV Pharmaceutical just made $29,800,000. Add in Blue Cross/Blue Shield, United Healthcare, Humana and others, that's over $100 million in ONE year. And of course, don't forget all the uninsured women who will need the shots, so that's several million dollars more that Medicaid will be spending...and we all know that the government is just rolling around in extra money right now.
So let's review: KV Pharmaceutical did not develop the drug (they merely pushed the paperwork on a drug that already existed and had been researched by the National Institute of Health-funded by TAX dollars), nor does the drug help less than 200,000 people a year. Therefore, it does not qualify for "orphan drug" status.
The "orphan drug" status is meant to help people with RARE disorders, not prey on women and babies for a obscene profit.
If those aren't enough facts for you, hear what Dr. Dombrowski has to say: http://www.youtube.com/watch?v=55J4VFnuhGU
March 14, 2011 - 3:12pmThis Comment
Reply